Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy

Podobne zapisy

• Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells
  od: Foy, Susan P., i wsp.
  Wydane: (2016)
• Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
  od: Foy, Susan P, i wsp.
  Wydane: (2013)
• Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer
  od: Foy, Susan P, i wsp.
  Wydane: (2014)
• Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice
  od: Foy, Susan P., i wsp.
  Wydane: (2016)
• Development of PROSTVAC immunotherapy in prostate cancer
  od: Singh, Parminder, i wsp.
  Wydane: (2015)